These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5402252)

  • 21. [Clinical use of the butydrine-pentaetythrite association].
    Ravera M
    Minerva Med; 1968 Oct; 59(86):4561-5. PubMed ID: 5697129
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical data on 20 patients treated with the association of butydrine and pentaerythritol tetranitrate].
    Rossi PL; Guarraggi A; Anfossi F
    Clin Ter; 1971 May; 57(4):345-50. PubMed ID: 5110948
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 24. [Continuous protection against angina pectoris-like disorders. Attack prevention without a nitrate pause].
    MMW Fortschr Med; 2003 Sep; 145(39):54. PubMed ID: 14649081
    [No Abstract]   [Full Text] [Related]  

  • 25. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of "pentrium", drug improving coronary circulation].
    Wasyluk J; Ruźyllo E
    Pol Tyg Lek; 1966 Nov; 21(48):1853-4. PubMed ID: 5979531
    [No Abstract]   [Full Text] [Related]  

  • 28. [Coronary vasodilators in surgery].
    Mijangos Lazcano D
    Rev Med Hosp Gen (Mex); 1965 Mar; 28(3):219-24. PubMed ID: 5829934
    [No Abstract]   [Full Text] [Related]  

  • 29. Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate).
    Albert M; Stansell MJ
    Metabolism; 1969 Aug; 18(8):635-45. PubMed ID: 4895062
    [No Abstract]   [Full Text] [Related]  

  • 30. A spectral analysis of coronary heart disease. Correlation of results of therapy using a long-acting nitrate compound.
    Hedges RN; Gordon WZ
    Angiology; 1965 Dec; 16(12):728-38. PubMed ID: 5842923
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anti-anginal activity of a beta-adrenergic blocking agent, butydrine, alone and in association with pentaerythritol tetranitrate, in the aged].
    Gatti A; Scotti G
    Clin Ter; 1967 May; 41(4):363-74. PubMed ID: 5614306
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of 70 cases of coronaropathy by a nitrogen derivative of prolonged action].
    Jouve A; Gerard R; Delaage M; Arnoux M
    Mars Med; 1967; 104(7):701-3. PubMed ID: 5609434
    [No Abstract]   [Full Text] [Related]  

  • 33. A clinical study comparing the effect of small doses of heparin with the effects of carbocromen and pentaerythrityl tetranitrate in angina pectoris. Some questions of the therapeutical mechanism of heparin.
    Goldberg GA; Suriadnova BA; Stepanov MA; Kochanko EP
    Cor Vasa; 1972; 14(2):81-95. PubMed ID: 5050956
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical experience with the association of a beta-blocking agent and pentaerythrite].
    Barbi G; Tallone G
    Minerva Cardioangiol; 1969 Feb; 17(2):139-41. PubMed ID: 5777637
    [No Abstract]   [Full Text] [Related]  

  • 35. Peritrate is no longer claimed to aid survival.
    Drug Ther Bull; 1966 Jun; 4(12):47-8. PubMed ID: 5947207
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of the systolic phase of the left ventricle in assessing the efficacy of therapy of patients with chronic coronary insufficiency].
    Shmeleva NK
    Ter Arkh; 1966 Sep; 38(9):77-81. PubMed ID: 4385082
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

  • 38. [Administration of synanthrin in therapy of coronary atherosclerosis].
    Zolotarev AE
    Fiziol Zh; 1970; 16(5):685-6. PubMed ID: 5507977
    [No Abstract]   [Full Text] [Related]  

  • 39. [Coronary disease. Therapeutic results in 2,841 ambulatory patients].
    Deibert K; Ihm P
    ZFA (Stuttgart); 1979 May; 55(14):902-8. PubMed ID: 452663
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of coronary insufficiency with beta-adrenergic blocking agents in association with a nitroderivative].
    Rinaldi AR; Zanacchi G
    Minerva Cardioangiol; 1971 Mar; 19(3):160-71. PubMed ID: 4396512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.